SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $836,418 | +5.9% | 6,900 | 0.0% | 0.13% | +11.4% |
| Q2 2023 | $790,188 | -16.9% | 6,900 | 0.0% | 0.11% | -22.4% |
| Q1 2023 | $951,027 | +6.4% | 6,900 | 0.0% | 0.15% | +1.4% |
| Q4 2022 | $894,102 | +17.2% | 6,900 | 0.0% | 0.14% | +10.7% |
| Q3 2022 | $763,000 | +67.3% | 6,900 | +130.0% | 0.13% | +59.8% |
| Q2 2019 | $456,000 | +91.6% | 3,000 | +50.0% | 0.08% | +90.7% |
| Q1 2019 | $238,000 | -27.2% | 2,000 | -33.3% | 0.04% | -36.8% |
| Q4 2018 | $327,000 | -32.6% | 3,000 | 0.0% | 0.07% | -18.1% |
| Q3 2018 | $485,000 | +83.7% | 3,000 | +50.0% | 0.08% | +76.6% |
| Q2 2018 | $264,000 | – | 2,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |